NCT03413553 is a NA clinical trial of immediate implant in Soft Tissue Augmentation, sponsored by Abeer hassan sharafuddin.

Who is sponsoring NCT03413553?

NCT03413553 is sponsored by Abeer hassan sharafuddin.

What drugs are being tested in NCT03413553?

Interventions in NCT03413553: immediate implant, connective tissue graft, platelet rich fibrin.

What condition does NCT03413553 study?

NCT03413553 studies Soft Tissue Augmentation.

Is NCT03413553 still recruiting?

NCT03413553 is currently completed. Last updated 3 August 2021.

Last reviewed 2021-08-03 · How we verify

NCT03413553

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Evaluation of Soft Tissue Augmentation Using CTG and PRF Around Immediately Placed Dental Implants Versus Immediate Implant Alone in Esthetic Zone .

Completed NA Last updated 3 August 2021

What this trial tests

NA trial testing immediate implant in Soft Tissue Augmentation in 20 participants. Completed in 15 January 2020.

Timeline

1 March 2018

Primary endpoint
30 September 2019

15 January 2020

Quick facts

Lead sponsor	Abeer hassan sharafuddin
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	20
Start date	1 March 2018
Primary completion	30 September 2019
Estimated completion	15 January 2020
Sites	1 location across Egypt

Drugs / interventions tested

immediate implant
connective tissue graft — full drug profile →
platelet rich fibrin — full drug profile →

Conditions studied

Soft Tissue Augmentation — all drugs for Soft Tissue Augmentation →

Sponsor

Abeer hassan sharafuddin — full company profile →

Who can join

Adults 18 to 50, any sex, with Soft Tissue Augmentation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main hypothesis to be certified is that the addition of Subepithelial Connective Tissue Graft (SCTG) and Platelet rich Fibrin (PRF) to immediately placed implants will not significantly differ from immediately placed implant alone as regard gingival tissue stability.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of immediate implant

Trials testing the same drug.

NCT05005585 — Vestibular Socket Therapy With Simultaneous Implant Placement Versus Contour Augmentation With Early Implant Placement · NA · unknown
NCT03425864 — PES After Soft Tissue Augmentation Using CTG Around Immediate Dental Implants Versus Immediate Dental Implants Alone in · NA · completed

Other recruiting trials for Soft Tissue Augmentation

Currently open trials in the same condition.

NCT06622759 — The Use of a Porcine Collagen Matrix for the Prevention of Buccal Bone Wall Resorption During Implant Placement in the A · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03413553 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Abeer hassan sharafuddin
Last refreshed: 3 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03413553.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing